4Kumar N, Vijayaraghavan B, Ramana KV, et al. Process for the preparation of fluoxetine hydrochloride via the etherification of N-methyl-3-hydroxy-3-phenylpropylamine with 1-chloro-4- (trifluoromethyl) benzene in sulfolane in the presence of alkali [P]. WO: 2001044166, 2001-06-21. (CA 2001, 135:45983)
5Agai Csongor E, Drexler F, Aracs Trischler Z, et al. Preparation of N-methyl-3-phenyl-3- [4- (trifluoromethyl) phenoxy]propylamine and acid addition salts [P]. WO: 9400416, 1994-01-06. (CA 1994, 120: 191314)
6Hilborn JW, Jurgens AR. Fluoxetine process from benzoylacetonitrile [P]. US: 6025517, 2000-02-15. (CA 2000, 132:151559)
7Molloy BB, Schmiegel KK. Aroxylphenylpropylamines [P].US: 4313896, 1982-02-02. (CA 1982, 96: 142447)
8Robertson DW, Krushinski JH, Wong DT, et al. Synthesis of carbon-14 and tritium-labeled fluoxetine, a selective serotonin uptake inhibitor [J]. J Labelled Compd Radiopharm, 1987, 24(11): 1397-1404. (CA 1987, 109: 6157)
9Wirth DD, Miller MS, Boini SK, et al. Identification and comparison of impurities in fluoxetine hydrochloride synthesized by seven different routes [J]. Org Process Res Dev, 2000, 4(6): 513-519. (CA 2001, 134: 21369)
10Reiter J, Simig G, Mezei T, et al. Preparation of N,N-dimethyl[3-phenyl-3- [4- (trifluoromethyl)phenoxy]propyl]amine p-toluenesulfonate as a pharmaceutical intermediate for the synthesis of fluoxetine, and a process for the preparation thereof[P]. WO: 2000021917, 2000-04-20. (CA 2000, 132:278978)
